NCT06733337View on ClinicalTrials.gov

A Study to Learn About the Safety of TALZENNA in People With Prostate Cancer.

Active, not recruitingOBSERVATIONAL

Enrollment

1

Participants

Timeline

Start Date

July 14, 2025

Primary Completion Date

June 22, 2029

Study Completion Date

June 22, 2029

Conditions

Prostate Cancer

Trial Locations (1)

Unknown

Pfizer Japan, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY